Not really the angle the market wants to see. And animals?
AD failed .. fair enough a second crack.. but can we stay focused on the antibiotic prize ?
What are the developments with the gram negative side?
How is the FDA progression?
AMR funding?
Bit frustrated seeing this Ann to be honest.
All seems like it’a far away at this stage. I guess that’s the nature of the BIO space..
Ann: New Canine Pilot Study Supports Further AD Investigation, page-36
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $592.7M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.5¢ | $1.302M | 3.974M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 713153 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 215665 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |